• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣植入术:走向极简的“支架样”手术。

Transcatheter aortic valve implantation: The road to a minimalist "stent-like" procedure.

机构信息

Department of Cardiology, CHU Rouen, U1096, Normandie University, UNIROUEN, 76000 Rouen, France.

Department of Cardiac Surgery, CHU Rouen, 76000 Rouen, France.

出版信息

Arch Cardiovasc Dis. 2022 Apr;115(4):196-205. doi: 10.1016/j.acvd.2022.03.004. Epub 2022 Apr 29.

DOI:10.1016/j.acvd.2022.03.004
PMID:35559901
Abstract

BACKGROUND

Since the first-in-man implantation of a transcatheter aortic stented valve in April 2002 in Rouen, the procedure has expanded worldwide. In our centre, all transfemoral procedures have been performed using local anaesthesia without transoesophageal echocardiographic monitoring.

AIM

To report our experience of transfemoral arterial transcatheter aortic valve implantation (TAVI) over the last 2 decades, following the evolution of devices, practices and indications.

METHODS

Between 2002 and 2021, 2097 consecutive patients had a TAVI procedure in our centre. Among them, 1780 underwent transfemoral arterial aortic valve implantation, and were subdivided into three groups according to the time period: before 2009; 2009-2014; and 2014-2021.

RESULTS

Median age was 85 years, and remained unchanged over time. The mean logistic EuroSCORE gradually decreased over time (28% before 2009 vs 15% for 2009-2014 vs 11% since 2014; P<0.001). Predilatation was performed almost systematically before 2009 (93%), but was rarely performed in the last period (14%; P<0.001). Thirty-day all-cause mortality decreased over time, and was only 1.4% in 2021. Length of stay decreased considerably, with a median duration of only 2 days after the procedure, and>70% of patients were discharged home within 72hours. Similarly, procedural duration, X-ray time and contrast volume decreased over time.

CONCLUSION

Transfemoral aortic valve implantation, performed as a minimalist "stent-like" procedure using only local anaesthesia, is feasible in the vast majority of patients, with excellent outcomes.

摘要

背景

自 2002 年 4 月首例经导管主动脉瓣植入术在鲁昂实施以来,该手术已在全球范围内得到推广。在我们中心,所有经股动脉入路的手术均采用局部麻醉进行,无需经食管超声心动图监测。

目的

报告我们在过去 20 年中使用局部麻醉进行经股动脉经导管主动脉瓣植入术(TAVI)的经验,该经验与器械、实践和适应证的发展有关。

方法

2002 年至 2021 年期间,我们中心共有 2097 例连续患者接受了 TAVI 手术。其中,1780 例行经股动脉主动脉瓣植入术,根据时间分为三组:2009 年前;2009-2014 年;2014-2021 年。

结果

中位年龄为 85 岁,且随时间推移保持不变。平均 logistic EuroSCORE 逐渐降低(2009 年前为 28%,2009-2014 年为 15%,2014 年后为 11%;P<0.001)。2009 年前几乎都进行预扩张(93%),但在最近一段时间很少进行(14%;P<0.001)。30 天全因死亡率随时间推移而降低,2021 年仅为 1.4%。住院时间显著缩短,术后仅 2 天,72 小时内出院的患者>70%。类似地,手术时间、X 线时间和造影剂用量随时间推移而减少。

结论

经股动脉主动脉瓣植入术作为一种微创的“支架样”手术,仅使用局部麻醉即可完成,在绝大多数患者中是可行的,且结果良好。

相似文献

1
Transcatheter aortic valve implantation: The road to a minimalist "stent-like" procedure.经导管主动脉瓣植入术:走向极简的“支架样”手术。
Arch Cardiovasc Dis. 2022 Apr;115(4):196-205. doi: 10.1016/j.acvd.2022.03.004. Epub 2022 Apr 29.
2
Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trial.SAPIEN 3 假体经股动脉主动脉瓣置换术后住院时间评估:一项法国多中心前瞻性观察性试验。
Arch Cardiovasc Dis. 2020 Jun-Jul;113(6-7):391-400. doi: 10.1016/j.acvd.2019.11.010. Epub 2020 May 14.
3
Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.经导管主动脉瓣植入术(TAVI)的极简方法:开放血管法与完全经皮法
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Oct 1;40(2):5-14. doi: 10.2478/prilozi-2019-0009.
4
Performing optimal transcatheter aortic valve implantation: The need for tailored use of transcatheter valves.实现经导管主动脉瓣植入术的优化:经导管瓣膜的个体化应用需求。
Arch Cardiovasc Dis. 2019 Aug-Sep;112(8-9):512-522. doi: 10.1016/j.acvd.2019.05.008. Epub 2019 Aug 29.
5
Trends over the past 4 years in population characteristics, 30-day outcomes and 1-year survival in patients treated with transcatheter aortic valve implantation.过去4年中接受经导管主动脉瓣植入术治疗的患者的人口统计学特征、30天预后及1年生存率趋势。
Arch Cardiovasc Dis. 2016 Aug-Sep;109(8-9):457-64. doi: 10.1016/j.acvd.2016.01.016. Epub 2016 Jun 21.
6
Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.连续患者队列中经股动脉植入可完全重新定位和回收的Lotus瓣膜且不进行常规预扩张后的手术及30天结局:单中心经验
Cardiovasc Revasc Med. 2018 Jan-Feb;19(1 Pt B):78-82. doi: 10.1016/j.carrev.2017.10.017. Epub 2017 Nov 4.
7
Feasibility and safety of transfemoral transcatheter aortic valve implantation performed with a percutaneous coronary intervention-like approach.经皮冠状动脉介入治疗样入路行经股动脉主动脉瓣置换术的可行性和安全性。
Arch Cardiovasc Dis. 2021 Aug-Sep;114(8-9):537-549. doi: 10.1016/j.acvd.2020.12.007. Epub 2021 Apr 22.
8
Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes.经颈动脉途径行经皮主动脉瓣植入术:可行性及临床结果。
Arch Cardiovasc Dis. 2017 Jun-Jul;110(6-7):389-394. doi: 10.1016/j.acvd.2016.10.005. Epub 2017 Apr 19.
9
Leaflet thrombosis following transcatheter aortic valve implantation.经导管主动脉瓣植入术后的叶状血栓。
J Cardiovasc Comput Tomogr. 2018 Jan-Feb;12(1):8-13. doi: 10.1016/j.jcct.2017.11.002. Epub 2017 Nov 9.
10
Comparison of clinical outcomes after transcarotid and transsubclavian versus transfemoral transcatheter aortic valve implantation: A propensity-matched analysis.经颈动脉与锁骨下动脉入路和经股动脉入路行经导管主动脉瓣植入术后临床结局的比较:倾向评分匹配分析。
Arch Cardiovasc Dis. 2020 Mar;113(3):189-198. doi: 10.1016/j.acvd.2020.01.001. Epub 2020 Feb 6.

引用本文的文献

1
Cardiac CT Beyond Coronaries: Focus on Structural Heart Disease.心脏 CT 检查不仅限于冠状动脉:关注结构性心脏病。
Curr Heart Fail Rep. 2023 Dec;20(6):484-492. doi: 10.1007/s11897-023-00635-9. Epub 2023 Nov 29.
2
New Practices in Transcatheter Aortic Valve Implantation: How I Do It in 2023.经导管主动脉瓣植入术的新实践:2023年我的操作方法
J Clin Med. 2023 Feb 8;12(4):1342. doi: 10.3390/jcm12041342.